Contraceptive Market by Product, Gender, Method, Distribution - Global Forecast 2025-2030- Product Image

Sale

Contraceptive Market by Product, Gender, Method, Distribution - Global Forecast 2025-2030

Report
195 Pages
October 2024
Region: Global
360iResearch™
ID: 4829811

UP TO €681EUR$697USD£568GBP OFF until Dec 31^st 2024

The Contraceptive Market grew from USD 48.43 billion in 2023 to USD 54.87 billion in 2024. It is expected to continue growing at a CAGR of 13.82%, reaching USD 119.89 billion by 2030.

The contraceptive market encompasses products and methods used to prevent pregnancy, including hormonal pills, patches, injections, IUDs, condoms, and implants. Its necessity arises primarily from the increasing need for family planning and the global emphasis on reproductive health. Applications extend beyond birth control, offering benefits such as hormonal regulation and treatment for conditions like polycystic ovary syndrome (PCOS). End-use spans across individual consumers, healthcare providers, and public health sectors. The key growth drivers include rising awareness, governmental initiatives for birth control, gender equality movements, and favorable drug policies. Additionally, advancements in technology leading to more effective and user-friendly products present substantial growth opportunities. For instance, there is growing interest in male contraceptives and biodegradable options, highlighting unmet needs and potential areas for expansion. However, challenges such as cultural and religious opposition, misinformation regarding contraceptive safety, and side-effects pose significant barriers. Limited access in developing regions, due to lack of infrastructure and healthcare services, further impedes growth. Opportunities exist in expanding education and awareness campaigns, which could help mitigate resistance and misinformation. There's also potential in personalized contraceptive products that cater to individual hormonal profiles, promising higher efficacy and lesser side effects. Furthermore, investing in research and development for non-hormonal and long-term contraceptive solutions presents significant commercial potential. The industry is characterized by rapid innovation and a competitive landscape, with major firms focusing on both product differentiation and affordable access to maintain and grow market presence. Emphasizing partnerships with non-profits and governmental organizations could also aid in expanding market reach. In essence, while the market faces considerable challenges, the push for gender inclusivity, technological advances, and broadened access afford promising avenues for growth and innovation.

Understanding Market Dynamics in the Contraceptive Market

The Contraceptive Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.

Market Drivers
- Increased awareness regarding sexual health and family planning
- Supportive government initiatives to encourage use and provision of contraceptive pills
Market Restraints
- Adverse health impacts of contraceptive products
Market Opportunities
- Introduction of affordable contraceptive methods with extensive R&D
- Availability of contraceptives through online distribution channels
Market Challenges
- Social concerns regarding contraceptive usage and issues with product marketing

Exploring Porter’s Five Forces for the Contraceptive Market

Porter’s Five Forces framework further strengthens the insights of the Contraceptive Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Contraceptive Market

External macro-environmental factors deeply influence the performance of the Contraceptive Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Contraceptive Market

The Contraceptive Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Contraceptive Market

The Contraceptive Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Key Company Profiles

The report delves into recent significant developments in the Contraceptive Market, highlighting leading vendors and their innovative profiles. These include Abbvie Inc., Acme Generics Pvt. Ltd., Afaxys, Inc., Agile Therapeutics, Inc., Amneal Pharmaceuticals LLC, ASKA Pharmaceutical Co., Ltd., Aurobindo Pharma Limited, Bayer AG, Church & Dwight Co., Inc., HLL Lifecare Limited, Insud Pharma, S.L., Johnson & Johnson Services, Inc., Lupin Limited, Mayne Pharma Group Limited, Merck & Co., Inc., Mithra Pharmaceuticals S.A., Okamoto Industries, Inc., Organon & Co., Perrigo Company plc, Pfizer Inc., Piramal Pharma Ltd., Reckitt Benckiser Group plc, RITEX GMBH, Sanofi S.A., Say It With A Condom, LLC., Syzygy Healthcare Solutions LLC, Teva Pharmaceutical Industries Ltd., TherapeuticsMD, Inc., TTK Healthcare Limited, Veru Inc., and Viatris Inc..

Market Segmentation & Coverage

This research report categorizes the Contraceptive Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
- Devices
  - Condoms
  - Diaphragm
  - IUDs
    - Copper IUDs
    - Hormonal IUDs
  - Subdermal Implants
  - Vaginal Rings
- Drugs
  - Injectables
  - Oral Contraceptive Pills
  - Transdermal Contraceptive Patch
Gender
- Female Contraceptive
- Male Contraceptive
Method
- Barrier
- Harmonal
Distribution
- Chain Pharmacy
- Clinics
- Government Network
- Hospital Pharmacy
- Independent Pharmacy
- Online Platform

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

What is the current size of the market, and how is it expected to grow?
Which products, segments, and regions present the most attractive investment opportunities?
What are the prevailing technology trends and regulatory factors influencing the market?
How do top vendors rank regarding market share and competitive positioning?
What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
4. Market Overview

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increased awareness regarding sexual health and family planning
5.1.1.2. Supportive government initiatives to encourage use and provision of contraceptive pills
5.1.2. Restraints
5.1.2.1. Adverse health impacts of contraceptive products
5.1.3. Opportunities
5.1.3.1. Introduction of affordable contraceptive methods with extensive R&D
5.1.3.2. Availability of contraceptives through online distribution channels
5.1.4. Challenges
5.1.4.1. Social concerns regarding contraceptive usage and issues with product marketing
5.2. Market Segmentation Analysis
5.2.1. Product: High inclination toward contraceptive drugs due to their ease of use and non-invasiveness
5.2.2. Gender: Significant adoption of female contraceptives due to availability of a wide range of products
5.2.3. Method: Rising preference for barrier methods of contraception that provide a physical and chemical barrier during sexual activities
5.2.4. Distribution Channel: Enhanced product distribution through online pharmacies due to their 24/7 services
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental

6. Contraceptive Market, by Product

6.1. Introduction
6.2. Devices
6.2.1. Condoms
6.2.2. Diaphragm
6.2.3. IUDs
6.2.3.1. Copper IUDs
6.2.3.2. Hormonal IUDs
6.2.4. Subdermal Implants
6.2.5. Vaginal Rings
6.3. Drugs
6.3.1. Injectables
6.3.2. Oral Contraceptive Pills
6.3.3. Transdermal Contraceptive Patch

7. Contraceptive Market, by Gender

7.1. Introduction
7.2. Female Contraceptive
7.3. Male Contraceptive

8. Contraceptive Market, by Method

8.1. Introduction
8.2. Barrier
8.3. Harmonal

9. Contraceptive Market, by Distribution

9.1. Introduction
9.2. Chain Pharmacy
9.3. Clinics
9.4. Government Network
9.5. Hospital Pharmacy
9.6. Independent Pharmacy
9.7. Online Platform

10. Americas Contraceptive Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Contraceptive Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Contraceptive Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. Richmond Biotech Company to buy Contraceptive biz for USD 100 Million
13.3.2. UK Launches First Trial of Hormone-free Male Birth Control pill
13.3.3. Aditxt Acquires Phexxi Contraceptive Gel-Maker Evofem for USD 100 million
13.3.4. Daré Bioscience Launches Phase III Hormone-free Contraceptive Trial
13.3.5. Lupin Launches Turqoz (Norgestrel and Ethinyl Estradiol) Tablets USP in the United States
13.3.6. Bayer and CrossBay Medical to Develop Novel Intrauterine System Inserter
13.3.7. Xiromed LLC Announces Launch of EnilloRing in the United States
13.3.8. Bayer Invests in USD 267.2 Million new Production Facility in Finland to Accelerate Global Access to Modern Contraception
13.3.9. NIH Center Grant Bolsters Male Contraceptive Research
13.3.10. Gates Foundation, Children’s Investment Fund Foundation, Pfizer and BD Company Expand Partnership for Greater Access to Injectable Contraceptive for Women
13.3.11. Perrigo Announces U.S. FDA Approval for Opill OTC Daily Oral Contraceptive
13.3.12. FDA Approves First Nonprescription Daily Oral Contraceptive
13.3.13. Sirona Acquires India’s First Vegan Condom Brand Bleu

List of Figures

FIGURE 1. CONTRACEPTIVE MARKET RESEARCH PROCESS
FIGURE 2. CONTRACEPTIVE MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL CONTRACEPTIVE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL CONTRACEPTIVE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 7. GLOBAL CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL CONTRACEPTIVE MARKET SIZE, BY GENDER, 2023 VS 2030 (%)
FIGURE 9. GLOBAL CONTRACEPTIVE MARKET SIZE, BY GENDER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL CONTRACEPTIVE MARKET SIZE, BY METHOD, 2023 VS 2030 (%)
FIGURE 11. GLOBAL CONTRACEPTIVE MARKET SIZE, BY METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2023 VS 2030 (%)
FIGURE 13. GLOBAL CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. AMERICAS CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. AMERICAS CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 17. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. CONTRACEPTIVE MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 23. CONTRACEPTIVE MARKET, FPNV POSITIONING MATRIX, 2023

List of Tables

TABLE 1. CONTRACEPTIVE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL CONTRACEPTIVE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CONTRACEPTIVE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. CONTRACEPTIVE MARKET DYNAMICS
TABLE 7. GLOBAL CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CONTRACEPTIVE MARKET SIZE, BY DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CONTRACEPTIVE MARKET SIZE, BY CONDOMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CONTRACEPTIVE MARKET SIZE, BY DIAPHRAGM, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CONTRACEPTIVE MARKET SIZE, BY IUDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CONTRACEPTIVE MARKET SIZE, BY COPPER IUDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CONTRACEPTIVE MARKET SIZE, BY HORMONAL IUDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CONTRACEPTIVE MARKET SIZE, BY SUBDERMAL IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CONTRACEPTIVE MARKET SIZE, BY VAGINAL RINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CONTRACEPTIVE MARKET SIZE, BY DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CONTRACEPTIVE MARKET SIZE, BY INJECTABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CONTRACEPTIVE MARKET SIZE, BY ORAL CONTRACEPTIVE PILLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CONTRACEPTIVE MARKET SIZE, BY TRANSDERMAL CONTRACEPTIVE PATCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CONTRACEPTIVE MARKET SIZE, BY FEMALE CONTRACEPTIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CONTRACEPTIVE MARKET SIZE, BY MALE CONTRACEPTIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CONTRACEPTIVE MARKET SIZE, BY BARRIER, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CONTRACEPTIVE MARKET SIZE, BY HARMONAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL CONTRACEPTIVE MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL CONTRACEPTIVE MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL CONTRACEPTIVE MARKET SIZE, BY GOVERNMENT NETWORK, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL CONTRACEPTIVE MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL CONTRACEPTIVE MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL CONTRACEPTIVE MARKET SIZE, BY ONLINE PLATFORM, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 44. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 45. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 46. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
TABLE 47. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 48. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 49. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 50. ARGENTINA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 51. BRAZIL CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 52. BRAZIL CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 53. BRAZIL CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
TABLE 54. BRAZIL CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 55. BRAZIL CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 56. BRAZIL CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 57. BRAZIL CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 58. CANADA CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 59. CANADA CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 60. CANADA CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
TABLE 61. CANADA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 62. CANADA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 63. CANADA CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 64. CANADA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 65. MEXICO CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 66. MEXICO CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 67. MEXICO CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
TABLE 68. MEXICO CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 69. MEXICO CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 70. MEXICO CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 71. MEXICO CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES CONTRACEPTIVE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 80. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 81. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 82. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
TABLE 83. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 84. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 85. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 86. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 87. ASIA-PACIFIC CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 88. AUSTRALIA CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 89. AUSTRALIA CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 90. AUSTRALIA CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
TABLE 91. AUSTRALIA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 92. AUSTRALIA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 93. AUSTRALIA CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 94. AUSTRALIA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 95. CHINA CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 96. CHINA CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 97. CHINA CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
TABLE 98. CHINA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 99. CHINA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 100. CHINA CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 101. CHINA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 102. INDIA CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 103. INDIA CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 104. INDIA CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
TABLE 105. INDIA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 106. INDIA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 107. INDIA CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 108. INDIA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 109. INDONESIA CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 110. INDONESIA CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 111. INDONESIA CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
TABLE 112. INDONESIA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 113. INDONESIA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 114. INDONESIA CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 115. INDONESIA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 116. JAPAN CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 117. JAPAN CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 118. JAPAN CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
TABLE 119. JAPAN CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 120. JAPAN CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 121. JAPAN CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 122. JAPAN CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 123. MALAYSIA CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 124. MALAYSIA CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 125. MALAYSIA CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
TABLE 126. MALAYSIA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 127. MALAYSIA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 128. MALAYSIA CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 129. MALAYSIA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 130. PHILIPPINES CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 131. PHILIPPINES CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 132. PHILIPPINES CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
TABLE 133. PHILIPPINES CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 134. PHILIPPINES CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 135. PHILIPPINES CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 136. PHILIPPINES CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 137. SINGAPORE CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 138. SINGAPORE CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 139. SINGAPORE CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
TABLE 140. SINGAPORE CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 141. SINGAPORE CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 142. SINGAPORE CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 143. SINGAPORE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 144. SOUTH KOREA CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 145. SOUTH KOREA CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 146. SOUTH KOREA CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
TABLE 147. SOUTH KOREA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 148. SOUTH KOREA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 149. SOUTH KOREA CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 150. SOUTH KOREA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 151. TAIWAN CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 152. TAIWAN CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 153. TAIWAN CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
TABLE 154. TAIWAN CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 155. TAIWAN CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 156. TAIWAN CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 157. TAIWAN CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 158. THAILAND CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 159. THAILAND CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 160. THAILAND CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
TABLE 161. THAILAND CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 162. THAILAND CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 163. THAILAND CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 164. THAILAND CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 165. VIETNAM CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 166. VIETNAM CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 167. VIETNAM CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
TABLE 168. VIETNAM CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 169. VIETNAM CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 170. VIETNAM CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 171. VIETNAM CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 180. DENMARK CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 181. DENMARK CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 182. DENMARK CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
TABLE 183. DENMARK CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 184. DENMARK CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 185. DENMARK CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 186. DENMARK CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 187. EGYPT CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 188. EGYPT CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 189. EGYPT CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
TABLE 190. EGYPT CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 191. EGYPT CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 192. EGYPT CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 193. EGYPT CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 194. FINLAND CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 195. FINLAND CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 196. FINLAND CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
TABLE 197. FINLAND CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 198. FINLAND CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 199. FINLAND CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 200. FINLAND CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 201. FRANCE CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 202. FRANCE CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 203. FRANCE CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
TABLE 204. FRANCE CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 205. FRANCE CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 206. FRANCE CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 207. FRANCE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 208. GERMANY CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 209. GERMANY CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 210. GERMANY CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
TABLE 211. GERMANY CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 212. GERMANY CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 213. GERMANY CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 214. GERMANY CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 215. ISRAEL CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 216. ISRAEL CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 217. ISRAEL CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
TABLE 218. ISRAEL CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 219. ISRAEL CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 220. ISRAEL CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 221. ISRAEL CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 222. ITALY CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 223. ITALY CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 224. ITALY CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
TABLE 225. ITALY CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 226. ITALY CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 227. ITALY CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 228. ITALY CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 229. NETHERLANDS CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 230. NETHERLANDS CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 231. NETHERLANDS CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
TABLE 232. NETHERLANDS CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 233. NETHERLANDS CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 234. NETHERLANDS CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 235. NETHERLANDS CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 236. NIGERIA CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 237. NIGERIA CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 238. NIGERIA CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
TABLE 239. NIGERIA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 240. NIGERIA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 241. NIGERIA CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 242. NIGERIA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 243. NORWAY CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 244. NORWAY CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 245. NORWAY CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
TABLE 246. NORWAY CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 247. NORWAY CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 248. NORWAY CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 249. NORWAY CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 250. POLAND CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 251. POLAND CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 252. POLAND CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
TABLE 253. POLAND CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 254. POLAND CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 255. POLAND CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 256. POLAND CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 257. QATAR CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 258. QATAR CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 259. QATAR CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
TABLE 260. QATAR CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 261. QATAR CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 262. QATAR CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 263. QATAR CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 264. RUSSIA CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 265. RUSSIA CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 266. RUSSIA CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
TABLE 267. RUSSIA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 268. RUSSIA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 269. RUSSIA CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 270. RUSSIA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 271. SAUDI ARABIA CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 272. SAUDI ARABIA CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 273. SAUDI ARABIA CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
TABLE 274. SAUDI ARABIA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 275. SAUDI ARABIA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 276. SAUDI ARABIA CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 277. SAUDI ARABIA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 278. SOUTH AFRICA CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 279. SOUTH AFRICA CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 280. SOUTH AFRICA CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
TABLE 281. SOUTH AFRICA CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 282. SOUTH AFRICA CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 283. SOUTH AFRICA CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 284. SOUTH AFRICA CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 285. SPAIN CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 286. SPAIN CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 287. SPAIN CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
TABLE 288. SPAIN CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 289. SPAIN CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 290. SPAIN CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 291. SPAIN CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 292. SWEDEN CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 293. SWEDEN CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 294. SWEDEN CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
TABLE 295. SWEDEN CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 296. SWEDEN CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 297. SWEDEN CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 298. SWEDEN CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 299. SWITZERLAND CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 300. SWITZERLAND CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 301. SWITZERLAND CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
TABLE 302. SWITZERLAND CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 303. SWITZERLAND CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 304. SWITZERLAND CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 305. SWITZERLAND CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 306. TURKEY CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 307. TURKEY CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 308. TURKEY CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
TABLE 309. TURKEY CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 310. TURKEY CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 311. TURKEY CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 312. TURKEY CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 313. UNITED ARAB EMIRATES CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 314. UNITED ARAB EMIRATES CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 315. UNITED ARAB EMIRATES CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
TABLE 316. UNITED ARAB EMIRATES CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 317. UNITED ARAB EMIRATES CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 318. UNITED ARAB EMIRATES CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 319. UNITED ARAB EMIRATES CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 320. UNITED KINGDOM CONTRACEPTIVE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 321. UNITED KINGDOM CONTRACEPTIVE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 322. UNITED KINGDOM CONTRACEPTIVE MARKET SIZE, BY IUDS, 2018-2030 (USD MILLION)
TABLE 323. UNITED KINGDOM CONTRACEPTIVE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 324. UNITED KINGDOM CONTRACEPTIVE MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 325. UNITED KINGDOM CONTRACEPTIVE MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 326. UNITED KINGDOM CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 327. CONTRACEPTIVE MARKET SHARE, BY KEY PLAYER, 2023
TABLE 328. CONTRACEPTIVE MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Contraceptive market, which are profiled in this report, include:

Abbvie Inc.
Acme Generics Pvt. Ltd.
Afaxys, Inc.
Agile Therapeutics, Inc.
Amneal Pharmaceuticals LLC
ASKA Pharmaceutical Co., Ltd.
Aurobindo Pharma Limited
Bayer AG
Church & Dwight Co., Inc.
HLL Lifecare Limited
Insud Pharma, S.L.
Johnson & Johnson Services, Inc.
Lupin Limited
Mayne Pharma Group Limited
Merck & Co., Inc.
Mithra Pharmaceuticals S.A.
Okamoto Industries, Inc.
Organon & Co.
Perrigo Company plc
Pfizer Inc.
Piramal Pharma Ltd.
Reckitt Benckiser Group plc
RITEX GMBH
Sanofi S.A.
Say It With A Condom, LLC.
Syzygy Healthcare Solutions LLC
Teva Pharmaceutical Industries Ltd.
TherapeuticsMD, Inc.
TTK Healthcare Limited
Veru Inc.
Viatris Inc.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	195
Published	October 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 54.87 Billion
Forecasted Market Value ( USD ) by 2030	$ 119.89 Billion
Compound Annual Growth Rate	13.8%
Regions Covered	Global
No. of Companies Mentioned	32

License	Format	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access		This is a single user license, allowing one user access to the product.	€3464EUR$3,545USD£2,892GBP €3849EUR$3,939USD£3,213GBP
ENTERPRISE LICENSE PDF, Excel and Online Access		This is an enterprise license, allowing all employees within your organization access to the product.	€6128EUR$6,272USD£5,116GBP €6809EUR$6,969USD£5,684GBP

Understanding Market Dynamics in the Contraceptive Market

Exploring Porter’s Five Forces for the Contraceptive Market

Applying PESTLE Analysis to the Contraceptive Market

Analyzing Market Share in the Contraceptive Market

Evaluating Vendor Success with the FPNV Positioning Matrix in the Contraceptive Market

Key Company Profiles

Market Segmentation & Coverage

The report provides a detailed overview of the market, exploring several key areas:

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Contraceptive Market Size, Share, & Trends Analysis Report By Product (Contraceptive Devices, Contraceptive Drugs), By Region, And Segment Forecasts, 2024 - 2030

Contraceptive Drugs and Devices Market Size, Share and Trends Analysis Report by Product (Contraceptive Drugs (Contraceptive Pills, Patch, Injectable), Contraceptive Devices), and Region 2024-2030

Female Contraceptive Market by Contraceptive Drug, Contraceptive Devices, Distribution Channel - Global Forecast 2025-2030

Contraceptive Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

Contraceptives - Market Insights, Competitive Landscape, and Market Forecast - 2030

About the Contraception Market